(Total Views: 583)
Posted On: 03/29/2020 5:09:59 PM
Post# of 154051
A question for the medical professionals on this board regarding Leronlimab's effect on cancer:
According to my understanding we've seen results of significant shrinkage of patients primary and metastatic tumors while being treated with Leronlimab.
Why haven't any of them experienced tumor lysis syndrome? Does the down regulation of the cytokine storm have anything to do with the lack of this SAE?
According to my understanding we've seen results of significant shrinkage of patients primary and metastatic tumors while being treated with Leronlimab.
Why haven't any of them experienced tumor lysis syndrome? Does the down regulation of the cytokine storm have anything to do with the lack of this SAE?
(2)
(0)
